The deal comes after the Supreme Court blocked a controversial bankruptcy plan for Purdue that shielded Sackler family ...

The Sackler family and Purdue Pharma, the maker of the addictive painkiller oxycontin, have reached a $7.4 billion settlement with a bipartisan coalition of 15 states for fueling the opioid crisis, ...

Purdue Pharma’s owners from the Sackler family ... reopening a path to end the longest and costliest corporate bankruptcy case stemming from the U.S. opioid crisis. The Sackler family members ...

The yearslong bankruptcy case could be coming to a close. Purdue Pharma’s owners in the Sackler family have agreed to a new $6.5 billion settlement to lawsuits over their role in the U.S. opioid ...

Purdue Pharma and the members of the Sackler family ... That provision garnered objection because, although Purdue filed for bankruptcy protections, the Sacklers themselves did not.

Members of the family who own OxyContin maker Purdue Pharma, and the company itself ... company’s board and have not taken distributions from Purdue since before the bankruptcy filing. The company ...

The bankruptcy case is Purdue Pharma LP, number 19-23649, in the US Bankruptcy Court for the Southern District of New York.

Supreme Court hears case that could shield Purdue Pharma owners from opioid lawsuits The Supreme Court heard arguments in one of the most important corporate bankruptcy cases in decades.

As the five-year anniversary of the Archdiocese of New Orleans bankruptcy case approaches, the judge wants to speed up settlement talks and is planning to name a third mediator — Judge Christopher ...